Stay updated with breaking news from Stephen Van Deventer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PreveCeutical Medical is blaming its former lawyer for writing a press release that was found to be misleading by a hearing panel at the B.C. Securities Commission; the company was cleared of allegations it breached the Securities Act.
PreveCeutical Medical is blaming its former lawyer for writing a press release that was found to be misleading by a hearing panel at the B.C. Securities Commission; the company was cleared of allegations it breached the Securities Act.
PreveCeutical Medical Inc. is providing an update with respect to the Management Cease Trade Order issued by the British Columbia Securities Commission under National Policy 12-203 - Management...
A Vancouver-based health sciences company that was attempting to develop synthetic scorpion venom withheld relevant information from investors, but that omission did not necessarily have an impact on the company's stock price, B.C.'s financial regulator has ruled.
A BCSC hearing panel determined PreveCeutical Medical Inc. and CEO Stephen Van Deventer did not meet the threshold of making misrepresentations.